Windward Bio is in full sail with a $165 million crossover financing to push its long-acting anti-TSLP antibody into phase 3, ...

Led by OrbiMed, with participation from RA Capital Management, Janus Henderson Investors, Sanofi Ventures, Harbour BioMed, and existing investors ...

Aclaris Therapeutics (NASDAQ:ACRS) provided a clinical program update on Tuesday, highlighting full top-line results from its phase I-A single-ascending dose (SAD) and multiple-ascending dose (MAD) st ...

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "TSLP Inhibitors and TSLP Receptor Antagonists: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering. This competitive ...

Inhaled anti-TSLP asthma therapy reduced FeNO and showed good safety in early trials. Find out what this means for asthma ...

The alternative text for this image may have been generated using AI. Thymic stromal lymphopoietin (TSLP) is an interleukin-7-like cytokine that is associated with the pathology of atopic dermatitis ...

Patients with acute asthma exacerbations who do not suppress eosinophils after a course of oral corticosteroids (OCS) may have slower clinical recovery, according to one study. In some patients with ...

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE:BX) today announced the launch of the Blackstone Life Sciences (“Blackstone”) portfolio company Uniquity Bio, a clinical-stage drug development company ...

March 8, 2010 — A genomewide association study has identified a locus on chromosome 5 associated with susceptibility to eosinophilic esophagitis (EoE). The disorder affects 1 person in 10,000 outside ...

The alternative text for this image may have been generated using AI. The cytokine thymic stromal lymphopoietin (TSLP) has previously been linked to allergic inflammatory diseases in humans. Now, ...

Healthy brinchial tube and constricted bronchial tube with asthma CSJ117, formulated as an engineered powder in hard capsules for delivery to the lungs via dry powder inhaler, may be the first inhaled ...